SA
Therapeutic Areas
Precision Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Novel Tumor-Specific ADC | Multiple human cancer types | Pre-clinical |
| New ADC | Human ovarian cancer | Pre-clinical |
Leadership Team at Precision Biologics
PM
Philip M. Arlen, MD
President and CEO
AT
Al Tsang
Chief Scientific Officer
MF
Massimo Fantini
Director, R&D